Redhill Biopharma
RDHL
#10414
Rank
โ‚น0.49 B
Marketcap
โ‚น95.85
Share price
-5.36%
Change (1 day)
-81.10%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น63,296. In 2017 the company made an earnings per share (EPS) of -โ‚น2,26,057 a decrease over its 2016 EPS that were of -โ‚น1,98,931.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,26,05713.64%
2016-โ‚น1,98,9319.12%
2015-โ‚น1,82,30168.01%
2014-โ‚น1,08,508-25.93%
2013-โ‚น1,46,485

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น335.08-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น686.65-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น325.15-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น56.97-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น110.32-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel